Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study

INTRODUCTION: The soluble urokinase-type plasminogen activator receptor (suPAR) has recently been associated with a decline in kidney function and incidence of chronic kidney disease in patients with cardiovascular disease undergoing cardiac catheterization, yet little is known whether suPAR is asso...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Int Rep
Main Authors: Schulz, Christina-Alexandra, Persson, Margaretha, Christensson, Anders, Hindy, George, Almgren, Peter, Nilsson, Peter M., Melander, Olle, Engström, Gunnar, Orho-Melander, Marju
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2016
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5362148/
https://ncbi.nlm.nih.gov/pubmed/28367534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2016.11.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados